Latest Listings And Ipos News

Integral Diagnostics has opened FY27 below expectations, with radiologist and sonographer shortages limiting revenue growth and pushing labour costs ahead of sales. The company expects FY27 revenue growth of 4% to 6% and a full-year operating EBITDA margin of 19.5% to 20.5%, with improvement weighted to the second half.

Adisyn has identified graphene at all 12 sampled locations on a full 200mm wafer, moving its low-temperature deposition platform beyond 1cm² laboratory coupons. The ASX-listed technology company ended September with A$14.4 million in cash and no debt, but commercial qualification remains ahead.

IGO delivered record Greenbushes spodumene production and a 49% jump in underlying EBITDA in the September quarter, while Nova approaches its final days of operation. The result strengthens the lithium portfolio’s earnings contribution, but Kwinana remains a substantial drag and Greenbushes’ next growth plan is not yet valued.

Killi Resources has extended its Lodestone magnetite system beyond the existing 110Mt Inferred Resource, with step-out drilling intersecting broad visual zones south of the resource boundary. The company ended September with A$16.4 million in cash as a second rig and a high-resolution magnetic survey moved the project into its next phase.

AnteoTech reported a quarter of technical milestones and commercial discussions across its battery and life sciences businesses, including new agreements with Xerabrid and Airspeeder. The company ended September with about A$11 million in cash, although an inconsistency in the Appendix 4C reconciliation needs clarification.

Chilwa Minerals finished the September quarter with only A$5,000 in cash, but its completed Nasdaq IPO has since delivered about A$4.5 million net and reopened the funding runway. The company is now pressing ahead with Mpyupyu West and Nakombe drilling, although the key exploration results remain outstanding.

Kaoko Metals has expanded its Chalkos exploration campaign to at least 15,000 metres after maiden drilling confirmed broad, shallow copper-silver mineralisation at Otniel. A $20 million placement leaves the ASX-listed explorer with $22.0 million in cash to fund the next phase, but the discovery remains at an early exploration stage.

Beforepay Group will replace CEO Jamie Twiss with deputy CEO Kasey Kaplan on 7 December, making an internal succession change as the fintech enters its next growth phase. Kaplan’s package includes A$600,000 fixed remuneration, annual incentives, equity rights and a potential six-year milestone plan worth up to A$10 million.

Orbit Resources has extended its Lewis Ponds exploration story with new sulphide intersections, an out-of-resource Quarry Lode result and improved metallurgical prospects. The progress comes alongside a cash balance of A$1.743 million, equivalent to just 0.89 quarters of funding at the reported expenditure rate.

Noxopharm has halted trading in its securities while it prepares an announcement about a capital raising. The suspension is scheduled to last until the earlier of the announcement or the start of trading on 2 November 2026, unless ASX decides otherwise.

GBM Resources has extended gold mineralisation beyond the existing 1Moz Twin Hills resource, including an 18-metre intersection grading 12.01g/t gold. Early flotation tests returned recoveries of up to 99%, while the company held $23.3 million in cash and no debt at quarter end.

Vital Metals has extended rare earth and niobium mineralisation beyond Tardiff’s 192.7 million tonne resource envelope, strengthening the case for an updated resource estimate and pre-feasibility study. But the ASX-listed developer ended September with A$2.4 million in cash, equivalent to just 1.87 quarters of funding before higher arbitration costs.